Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.

Published

Journal Article

Treatment options for primary cutaneous aspergillosis in neonates are limited by the lack of pharmacokinetic and safety data of newer antifungal agents that are effective against Aspergillus spp. We report the successful treatment of cutaneous aspergillosis in an extremely low-birth-weight preterm infant with liposomal amphotericin B, voriconazole and micafungin, and provide pharmacokinetic profiles for voriconazole and micafungin.

Full Text

Duke Authors

Cited Authors

  • Santos, RP; Sánchez, PJ; Mejias, A; Benjamin, DK; Walsh, TJ; Patel, S; Jafri, HS

Published Date

  • April 2007

Published In

Volume / Issue

  • 26 / 4

Start / End Page

  • 364 - 366

PubMed ID

  • 17414408

Pubmed Central ID

  • 17414408

Electronic International Standard Serial Number (EISSN)

  • 1532-0987

International Standard Serial Number (ISSN)

  • 0891-3668

Digital Object Identifier (DOI)

  • 10.1097/01.inf.0000258698.98370.89

Language

  • eng